Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. Developing and petro-rich nations are pushing world demand for pharmaceuticals. Pharmacists are favoring OTCs, and are a driving force behind a new class of 'behind the counter' (BTC) drugs. The aging of the population and an increase in medical conditions generally continues to bode well for OTC products. For the purpose of this study, Kalorama Information has divided products into five general segments:

• Analgesics
• Allergy, Cough, Cold, Flu Remedies
• Gastrointestinal Remedies
• Dermatologics
• Others (including: Smoking cessation products, Sleepaids, Dental rinses, fluorides, Hair growth remedies, Diet aids)

As part of thorough coverage of the OTC market, this report includes:

• Current Market Size and Forecasts by Product Type
• Regional Breakout of Revenues (including Asia Pacific and Africa, Europe, North America, South America regions)
• The Combined Wisdom of over 100 Market Experts interviewed for This Report
• Over 110 Figures and Tables to Make Points in the Text Clear
• Overview of Over the Counter Market
• Review of Successful OTC Products
• Market Share
• Company Profiles
• Discussion of Issues and Trends in OTC

Knowledge of issues affecting the world market for OTC drugs are critical to understanding this market and this report tackles the following issues and trends:

• Consumer Advertising and Promotion
• Demographics
• Prescription vs. OTC Industry
• Rx-to-OTC Switch Industry
• Economic Trends
• Health Insurance Issues and Trends
• Consumer Issues and Trends
• Regulatory Environment

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

The OTC market is vast with many competitors. The following main competitors are profiled in this report:

• Abbott Laboratories
• Novartis
• Wyeth
• Bayer Consumer Health
• Boehringer Ingelheim
• Chattem
• GlaxoSmithKline
• McNeil Consumer (Johnson & Johnson)
• Novartis Pharmaceuticals
• Procter & Gamble
• Reckitt Benckiser
• Sanofi-Aventis
• Schering-Plough
• Taisho Pharmaceutical
• Takeda
• Wyeth Consumer

Related Reports:

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Jun 1, 2009 - KLI2155319 - $3,995.00

Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
May 1, 2009 - KLI2091313 - $3,995.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition
May 1, 2009 - KLI2123150 - $4,995.00

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
May 1, 2009 - KLI1829596 - $3,500.00

World Markets for Point of Care Diagnostics 2009-13
Apr 1, 2009 - KLI2158347 - $3,300.00

World Market for Dialysis Equipment and Services
Apr 1, 2009 - KLI2041112 - $3,500.00

Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Apr 1, 2009 - KLI2123096 - $1,995.00

Clinical Nutrition Products: World Markets, 3rd Edition
Feb 1, 2009 - KLI2089645 - $3,795.00